Sustained Complete Response to a Short Course of Subcutaneous Daratumumab in Multi-Refractory Immune Thrombocytopenia. Mediterranean Journal of Hematology and Infectious Diseases, [S. l.], v. 18, n. 1, p. e2026069, 2026. DOI: 10.4084/MJHID.2026.069. Disponível em: https://www.mjhid.org/mjhid/article/view/6466. Acesso em: 2 sep. 2026.